Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.

Huang LY, Chang CC, Lee YS, Huang JJ, Chuang SH, Chang JM, Kao KJ, Lau GM, Tsai PY, Liu CW, Lin HS, Gish RG, Lau JY.

Cancer Chemother Pharmacol. 2014 Sep;74(3):511-20. doi: 10.1007/s00280-014-2540-7. Epub 2014 Jul 20.

PMID:
25038613
2.

Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo.

Huang LY, Chang CC, Lee YS, Chang JM, Huang JJ, Chuang SH, Kao KJ, Lau GM, Tsai PY, Liu CW, Lin HS, Lau JY.

Mol Cancer Ther. 2014 Jun;13(6):1419-30. doi: 10.1158/1535-7163.MCT-13-0700. Epub 2014 Apr 2.

3.

An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region.

Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M.

Liver Int. 2012 Feb;32(2):339-45. doi: 10.1111/j.1478-3231.2011.02684.x. Epub 2011 Dec 5.

PMID:
22142261
4.

Hepatic expression of cell proliferation markers and growth factors in giant cell hepatitis: implications for the pathogenetic mechanisms involved.

Fang JW, González-Peralta RP, Chong SK, Lau GM, Lau GM, Lau JY.

J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):65-72. doi: 10.1097/MPG.0b013e3181f85a87. Erratum in: J Pediatr Gastroenterol Nutr. 2011 Dec;53(6):701.

PMID:
21119537
5.

Handwriting characteristics among secondary students with and without physical disabilities: a study with a computerized tool.

Li-Tsang CW, Au RK, Chan MH, Chan LW, Lau GM, Lo TK, Leung HW.

Res Dev Disabil. 2011 Jan-Feb;32(1):207-16. doi: 10.1016/j.ridd.2010.09.015. Epub 2010 Oct 28.

PMID:
21035302
6.

Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.

Lau GM, Lau GM, Yu GL, Gelman IH, Gutowski A, Hangauer D, Fang JW.

Dig Dis Sci. 2009 Jul;54(7):1465-74. doi: 10.1007/s10620-008-0519-0. Epub 2008 Nov 1.

PMID:
18979199

Supplemental Content

Support Center